New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: The gelatin sponge/chorioallantoic membrane assay

Domenico Ribatti, Anna Gualandris, Maria Bastaki, Angela Vacca, Monica Iurlaro, Luisa Roncali, Marco Presta

Research output: Contribution to journalArticle

Abstract

Several methods for the in vivo study of angiogenesis are available, and each angiogenic assay presents distinct advantages and disadvantages. In this study, we present a new method for the quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane (CAM), based on the implantation of gelatin sponges on the top of growing CAM, on day 8 of incubation. After implantation, the sponges were treated with a stimulator (recombinant human basic fibroblast growth factor, FGF2) or an inhibitor (a rabbit polyclonal anti-FGF2 antibody) of blood vessel formation. Blood vessels growing vertically into the sponge and at the boundary between sponge and surrounding CAM mesenchyme were counted by a morphometric method on day 12. In addition, to assess whether the gelatin sponge is an appropriate vehicle to deliver cultured cells and evaluate their angiogenic potential, mouse aortic endothelial cells were cotransfected with human FGF2 and the Escherichia coli β-galactosidase (β-GAL) reporter gene. Stable transfectants were absorbed by the sponge, and evaluation of the angiogenic response was paralleled by β-GAL staining to visualize implanted cells. This technique may facilitate the discovery and development of agonists or antagonists of angiogenesis.

Original languageEnglish
Pages (from-to)455-463
Number of pages9
JournalJournal of Vascular Research
Volume34
Issue number6
Publication statusPublished - Nov 1997

Fingerprint

Chorioallantoic Membrane
Porifera
Chick Embryo
Gelatin
Fibroblast Growth Factor 2
Blood Vessels
Galactosidases
Mesoderm
Reporter Genes
Anti-Idiotypic Antibodies
Cultured Cells
Endothelial Cells
Staining and Labeling
Escherichia coli
Rabbits

Keywords

  • β-Galactosidase
  • Angiogenesis
  • Antiangiogenesis
  • Chorioallantoic membrane
  • Fibroblast growth factor
  • Gelatin sponge

ASJC Scopus subject areas

  • Physiology

Cite this

New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane : The gelatin sponge/chorioallantoic membrane assay. / Ribatti, Domenico; Gualandris, Anna; Bastaki, Maria; Vacca, Angela; Iurlaro, Monica; Roncali, Luisa; Presta, Marco.

In: Journal of Vascular Research, Vol. 34, No. 6, 11.1997, p. 455-463.

Research output: Contribution to journalArticle

Ribatti, Domenico ; Gualandris, Anna ; Bastaki, Maria ; Vacca, Angela ; Iurlaro, Monica ; Roncali, Luisa ; Presta, Marco. / New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane : The gelatin sponge/chorioallantoic membrane assay. In: Journal of Vascular Research. 1997 ; Vol. 34, No. 6. pp. 455-463.
@article{a85bd8a2606a48afa1452fef87dcdff1,
title = "New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: The gelatin sponge/chorioallantoic membrane assay",
abstract = "Several methods for the in vivo study of angiogenesis are available, and each angiogenic assay presents distinct advantages and disadvantages. In this study, we present a new method for the quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane (CAM), based on the implantation of gelatin sponges on the top of growing CAM, on day 8 of incubation. After implantation, the sponges were treated with a stimulator (recombinant human basic fibroblast growth factor, FGF2) or an inhibitor (a rabbit polyclonal anti-FGF2 antibody) of blood vessel formation. Blood vessels growing vertically into the sponge and at the boundary between sponge and surrounding CAM mesenchyme were counted by a morphometric method on day 12. In addition, to assess whether the gelatin sponge is an appropriate vehicle to deliver cultured cells and evaluate their angiogenic potential, mouse aortic endothelial cells were cotransfected with human FGF2 and the Escherichia coli β-galactosidase (β-GAL) reporter gene. Stable transfectants were absorbed by the sponge, and evaluation of the angiogenic response was paralleled by β-GAL staining to visualize implanted cells. This technique may facilitate the discovery and development of agonists or antagonists of angiogenesis.",
keywords = "β-Galactosidase, Angiogenesis, Antiangiogenesis, Chorioallantoic membrane, Fibroblast growth factor, Gelatin sponge",
author = "Domenico Ribatti and Anna Gualandris and Maria Bastaki and Angela Vacca and Monica Iurlaro and Luisa Roncali and Marco Presta",
year = "1997",
month = "11",
language = "English",
volume = "34",
pages = "455--463",
journal = "Journal of Vascular Research",
issn = "1018-1172",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane

T2 - The gelatin sponge/chorioallantoic membrane assay

AU - Ribatti, Domenico

AU - Gualandris, Anna

AU - Bastaki, Maria

AU - Vacca, Angela

AU - Iurlaro, Monica

AU - Roncali, Luisa

AU - Presta, Marco

PY - 1997/11

Y1 - 1997/11

N2 - Several methods for the in vivo study of angiogenesis are available, and each angiogenic assay presents distinct advantages and disadvantages. In this study, we present a new method for the quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane (CAM), based on the implantation of gelatin sponges on the top of growing CAM, on day 8 of incubation. After implantation, the sponges were treated with a stimulator (recombinant human basic fibroblast growth factor, FGF2) or an inhibitor (a rabbit polyclonal anti-FGF2 antibody) of blood vessel formation. Blood vessels growing vertically into the sponge and at the boundary between sponge and surrounding CAM mesenchyme were counted by a morphometric method on day 12. In addition, to assess whether the gelatin sponge is an appropriate vehicle to deliver cultured cells and evaluate their angiogenic potential, mouse aortic endothelial cells were cotransfected with human FGF2 and the Escherichia coli β-galactosidase (β-GAL) reporter gene. Stable transfectants were absorbed by the sponge, and evaluation of the angiogenic response was paralleled by β-GAL staining to visualize implanted cells. This technique may facilitate the discovery and development of agonists or antagonists of angiogenesis.

AB - Several methods for the in vivo study of angiogenesis are available, and each angiogenic assay presents distinct advantages and disadvantages. In this study, we present a new method for the quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane (CAM), based on the implantation of gelatin sponges on the top of growing CAM, on day 8 of incubation. After implantation, the sponges were treated with a stimulator (recombinant human basic fibroblast growth factor, FGF2) or an inhibitor (a rabbit polyclonal anti-FGF2 antibody) of blood vessel formation. Blood vessels growing vertically into the sponge and at the boundary between sponge and surrounding CAM mesenchyme were counted by a morphometric method on day 12. In addition, to assess whether the gelatin sponge is an appropriate vehicle to deliver cultured cells and evaluate their angiogenic potential, mouse aortic endothelial cells were cotransfected with human FGF2 and the Escherichia coli β-galactosidase (β-GAL) reporter gene. Stable transfectants were absorbed by the sponge, and evaluation of the angiogenic response was paralleled by β-GAL staining to visualize implanted cells. This technique may facilitate the discovery and development of agonists or antagonists of angiogenesis.

KW - β-Galactosidase

KW - Angiogenesis

KW - Antiangiogenesis

KW - Chorioallantoic membrane

KW - Fibroblast growth factor

KW - Gelatin sponge

UR - http://www.scopus.com/inward/record.url?scp=0031469270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031469270&partnerID=8YFLogxK

M3 - Article

C2 - 9425998

AN - SCOPUS:0031469270

VL - 34

SP - 455

EP - 463

JO - Journal of Vascular Research

JF - Journal of Vascular Research

SN - 1018-1172

IS - 6

ER -